<div id="readability-page-1"><div> <p>By Katherine Hamilton</p> <pre></pre> <p>   Nike recorded a lower profit and said it expects revenue to a decline in its current quarter. The stock fell 11% to $58.62 in after-hours trading Thursday. </p> <p>   Cassava Sciences said the FDA had placed a hold on its trial for a drug to treat epilepsy. Shares slid 13% to $2.49 after the bell. </p> <p>   KB Home delivered fewer homes and recorded a lower profit in its most recent quarter. The stock declined 3.6% to $60.50. </p> <pre></pre> <p>   Write to Katherine Hamilton at katherine.hamilton@wsj.com </p> <pre></pre> <p>   (END) Dow Jones Newswires</p> <p>   December 18, 2025 18:54 ET (23:54 GMT)</p><p>Copyright (c) 2025 Dow Jones &amp; Company, Inc.</p></div></div>

耐克

SAVA

<p>耐克的股票下跌了 11%，至 58.62 美元，此前報告顯示利潤下降並預計收入將減少。Cassava Sciences 的股票下滑了 13%，至 2.49 美元，因為 FDA 暫停了其癲癇藥物的臨牀試驗。KB Home 的股票因交付的房屋減少和利潤下降而下跌了 3.6%，至 60.50 美元</p>

值得關注的股票：耐克、Cassava Sciences、KB Home